DITTO is a menstrual health company on a mission to break the taboo and close the research gap that has left women chronically underserved. Founded by neuroscientist and nutrition scientist Alice van der Schoot, DITTO launched its first product in 2025, combining clinical research and nutrient delivery technology to build trusted solutions for the menstrual cycle. DITTO also translates emerging research for a community of over 300,000, helping women understand their experiences, stay up to date, and feel equipped to advocate for themselves in a world that left them feeling unheard. DITTO is fast becoming the scientific authority in menstrual health, building the research infrastructure and science-led products this category has never had.
DITTO: Venture Capital Funding History
DITTO
DITTO
- Health
- London, United Kingdom
- £4.5m
- dittodaily.com
- Update Information
More venture news
- 3 Nov 2026

1nhaler1nhaler lands a £2m follow-on round led by Archangels to test its pop-up cardboard asthma inhaler in patients
Follow-onHealth - 20 Oct 2026

XRlabsXRlabs raises a £6.5m seed round led by Playground Global to embed AI Surgical Intelligence into operating rooms
SeedHealth - 17 Nov 2025

1nhaler1nhaler secures £1.5m in further seed funding led by Archangels to advance its pop-up cardboard inhaler
ExtensionHealth
